Immunotherapy and Antivascular Targeted Therapy in Patients’ Treatment with Concurrent Malignant Tumors after Organ Transplantation: Opportunity or Challenge

<div>The fluctuation of tumor indexes before and after esophageal tumor treatment. CA: glycoantigens; AFP: alpha-fetoprotein; CEA: carcinoembryonic antigen.</div>

Journal of Immunology Research

fig7

Figure 7

Figure 7: Immunotherapy and Antivascular Targeted Therapy in Patients’ Treatment with Concurrent Malignant Tumors after Organ Transplantation: Opportunity or Challenge 

Figure 7 | Immunotherapy and Antivascular Targeted Therapy in Patients’ Treatment with Concurrent Malignant Tumors after Organ Transplantation: Opportunity or Challenge 